Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 52 results for sciatica

  1. NICE encourages further research into epiduroscopic lumbar discectomy through the sacral hiatus for sciatica and may update the guidance on publication of further evidence. Research studies should include details of patient selection, complications and long-term results.

    research into epiduroscopic lumbar discectomy through the sacral hiatus for sciatica and may update the guidance on publication of...

    Research recommendation
    Published
    14 February 2017

  2. Automated percutaneous mechanical lumbar discectomy (HTG88)

    Evidence-based recommendations on automated percutaneous mechanical lumbar discectomy. This involves using an automated device to cut and remove the part of the disc that’s pressing on the nerve.

    HealthTech guidance
    Published
    23 November 2005
    View recommendations

    Sections for HTG88

  3. Percutaneous electrical nerve stimulation for refractory neuropathic pain (HTG308)

    Evidence-based recommendations on percutaneous electrical nerve stimulation for refractory neuropathic pain. This involves inserting electrode needles underneath the skin connected to a stimulator device.

    HealthTech guidance
    Published
    27 March 2013
    View recommendations

    Sections for HTG308

  4. Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain (HTG399)

    Evidence-based recommendations on percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain. This involves relieving low back pain by delivering heat energy to the damaged disc.

    HealthTech guidance
    Published
    27 January 2016
    View recommendations

    Sections for HTG399

  5. Transaxial interbody lumbosacral fusion for severe chronic low back pain (HTG478)

    Evidence-based recommendations on transaxial interbody lumbosacral fusion for low back pain in adults. This involves removing a damaged disc through a small cut at the base of the spine, and replacing it with an artificial implant.

    HealthTech guidance
    Published
    25 July 2018
    View recommendations

    Sections for HTG478

  6. Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain (HTG641)

    Evidence-based recommendations on neurostimulation of lumbar muscles for refractory non-specific chronic low back pain in adults. This involves implanting a pulse generator under the skin of the upper buttock or lower back, which the person can use to manage their pain.

    HealthTech guidance
    Published
    22 September 2022
    View recommendations

    Sections for HTG641

  7. NICE encourages further research into percutaneous electrothermal treatment of the intervertebral disc  annulus. Further research should document details of patient selection, including the duration of their symptoms. It should report precise details of the technique used for treatment. Outcome measures should include pain relief and quality of life. Long-term follow-up data should include details of any subsequent procedures.

    electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica raises no major safety concerns. The evidence...

    Research recommendation
    Published
    15 March 2016

  8. Percutaneous intradiscal laser ablation in the lumbar spine (HTG230)

    Evidence-based recommendations on percutaneous intradiscal laser ablation in the lumbar spine. This involves using a laser to destroy part of the disc, with the aim of shrinking it.

    HealthTech guidance
    Published
    22 September 2010
    View recommendations

    Sections for HTG230

  9. iFuse for treating chronic sacroiliac joint pain (HTG488)

    Evidence-based recommendations on iFuse for treating chronic sacroiliac joint pain.

    HealthTech guidance
    Last updated
    30 August 2022
    View recommendations

    Sections for HTG488

  10. Pharmacological therapies:- What is the clinical and cost effectiveness of codeine with and without paracetamol for the acute management of low back pain?

    Source guidance details Comes from guidance Low back pain and sciatica in over 16s: assessment and management Number NG59 Date

    Research recommendation
    Published
    13 February 2017

  11. Pharmacological therapies:- What is the clinical and cost effectiveness of benzodiazepines for the acute management of low back pain?

    Source guidance details Comes from guidance Low back pain and sciatica in over 16s: assessment and management Number NG59 Date

    Research recommendation
    Published
    13 February 2017

  12. Digital technologies for managing non-specific low back pain: early value assessment (HTG712)

    Early value assessment (EVA) guidance on digital technologies for managing non-specific low back pain in people 16 years and over.

    HealthTech guidance
    Published
    5 March 2024
    View recommendations

    Sections for HTG712

  13. Radiofrequency denervation:- What is the clinical and cost effectiveness of radiofrequency denervation for chronic low back pain in the long term?

    Source guidance details Comes from guidance Low back pain and sciatica in over 16s: assessment and management Number NG59 Date

    Research recommendation
    Published
    13 February 2017

  14. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (NG193)

    This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.

    NICE guideline
    Published
    7 April 2021
    View recommendations

    Sections for NG193

  15. Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain (MIB238)

    NICE has developed a medtech innovation briefing (MIB) on Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain .

    Medtech innovation briefing
    Published
    8 December 2020